Mediators of ocular angiogenesis
- PMID: 20090210
- PMCID: PMC3306772
- DOI: 10.1007/s12041-009-0068-0
Mediators of ocular angiogenesis
Abstract
Angiogenesis is the formation of new blood vessels from pre-existing vasculature. Pathologic angiogenesis in the eye can lead to severe visual impairment. In our review, we discuss the roles of both pro-angiogenic and anti-angiogenic molecular players in corneal angiogenesis, proliferative diabetic retinopathy, exudative macular degeneration and retinopathy of prematurity, highlighting novel targets that have emerged over the past decade.
References
-
- Abdiu O, Van Setten G. Antiangiogenic activity in tears: presence of pigment-epithelium-derived factor. New insights and preliminary results? Ophthalmic Res. 2008;40:16–18. - PubMed
-
- Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin. Immunopathol. 2008;30:65–84. - PubMed
-
- Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with diabetic retinopathy. Am. J. Ophthalmol. 1994;118:445–450. - PubMed
-
- Alon T, Hemo I, Itin A, Pe’er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1995;1:1024–1028. - PubMed
-
- Ambati BK, Joussen AM, Ambati J, Moromizato Y, Guha C, Javaherian K, et al. Angiostatin inhibits and regresses corneal neovascularization. Arch. Ophthalmol. 2002;120:1063–1068. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources